Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118 for the Treatment of CLN1 Disease | DNA RNA and Cells

Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118 for the Treatment of CLN1 Disease

Related Keywords

Hamburg ,Germany ,United States ,Canada ,Dallas ,Texas ,Jagdeep Wahlia ,Suyash Prasad ,Ceroid Lipofuscinosis ,Jagdeeps Walia ,Head Of Research ,I Taysha Gene Therapies Inc ,Queen University ,Development Of Taysha ,European Commission ,Drug Administration ,Nasdaq ,Kingston Health Sciences Centre ,European Union ,University Of Rochester ,Queen University In Ontario ,Health Canada ,Research Department Of Pediatrics ,Taysha Gene Therapies Announces Initiation ,Clinical Development ,United Statesi December ,Taysha Gene Therapies ,Clinical Trial Application ,Chief Medical Officer ,Clinical Geneticist ,Associate Professor Head ,Medical Genetics ,Kingston Health Sciences ,Infantile Neuronal Ceroid Lipofuscinosis ,Biologics ,Na ,Gene Therapy ,Dirna ,Unai ,Antisense ,Oligonucleotides ,Cells ,Cell Therapy ,Stem Cells ,